{
    "2021-11-22": [
        [
            {
                "time": "",
                "original_text": "3年大涨7倍！遭高瓴减持后，千亿医药巨头赴港IPO 减持股份",
                "features": {
                    "keywords": [
                        "高瓴减持",
                        "医药巨头",
                        "赴港IPO",
                        "减持股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英医药通过聆讯：年营收31亿 在A股市值已超千亿",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "医药",
                        "聆讯",
                        "市值超千亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国君固收天津泰达控股债券投资价值深度分析：稳如“泰”山，收益必“达”",
                "features": {
                    "keywords": [
                        "国君固收",
                        "泰达控股",
                        "债券投资",
                        "收益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "债券"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "专访勃林格殷格翰张维：中国CMO业务飞速扩展 多款新药受益于早期临床的全球同步",
                "features": {
                    "keywords": [
                        "勃林格殷格翰",
                        "CMO业务",
                        "新药",
                        "全球同步"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "一周IPO观察：网易云、微博卫龙、凯莱英通过港交所聆讯；能源EaaS公司递交招股书",
                "features": {
                    "keywords": [
                        "IPO",
                        "凯莱英",
                        "聆讯",
                        "网易云",
                        "微博卫龙",
                        "能源EaaS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药",
                        "能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康：医保谈判结束 医药板块有所回暖",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "医保谈判",
                        "医药板块",
                        "回暖"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "追高加仓凯莱英（002821.SZ），顶级医药基金经理为何看好？",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "追高加仓",
                        "医药基金",
                        "经理看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821)签订重大合同，业绩显著提速可期",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "重大合同",
                        "业绩提速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}